Smith Shawna N, Moureau Nancy, Vaughn Valerie M, Boldenow Tanya, Kaatz Scott, Grant Paul J, Bernstein Steven J, Flanders Scott A, Chopra Vineet
Division of General Internal Medicine, Department of Medicine, University of Michigan Health System, Ann Arbor, Michigan; Quantitative Methods Program, Institute for Social Research, University of Michigan, Ann Arbor, Michigan.
PICC Excellence, Hartwell, Georgia.
J Vasc Interv Radiol. 2017 May;28(5):749-756.e2. doi: 10.1016/j.jvir.2017.02.005. Epub 2017 Mar 11.
To evaluate patterns and predictors of peripherally inserted central catheter (PICC)-related occlusion.
Data from a multihospital study were used to examine factors associated with PICC occlusion. Occlusion was defined if documented in the medical record or when tissue plasminogen activator was administered for occlusion-related concerns. Mixed-effects logistic regression was used to predict occlusion, controlling for patient-, provider-, device-, and hospital-level characteristics.
A total of 14,278 PICCs placed in 13,408 patients were included. Of these, occlusion developed in 1,716 PICCs (12%) in 1,684 patients. The most common indications for PICC insertion were intravenous antibiotic therapy (32.7%), difficult intravenous access (21.5%), and central access (13.7%). PICCs placed in the right arm had decreased odds of occlusion compared with those in the left arm (odds ratio [OR] = 0.82; 95% confidence interval [CI] = 0.72-0.94). Verification of catheter tip position following insertion was associated with reduction in occlusion (OR = 0.75; 95% CI = 0.61-0.92). Although normal saline solution or heparin flushes did not reduce occlusion, PICCs flushed with normal saline solution and "locked" with heparin were less likely to become occluded (OR = 0.54; 95% CI = 0.33-0.88). Compared with single-lumen devices, double- and triple-lumen PICCs were associated with greater incidences of occlusion (double, OR = 3.07; 95% CI = 2.56-3.67; triple, OR = 3.72; 95% CI = 2.92-4.74). Catheter tip malposition was also associated with occlusion (OR = 1.46; 95% CI = 1.14-1.87).
Several patient, provider, and device characteristics appear associated with PICC occlusion. Interventions targeting these factors may prove valuable in reducing this complication.
评估经外周静脉穿刺中心静脉导管(PICC)相关堵塞的模式及预测因素。
来自一项多医院研究的数据用于检验与PICC堵塞相关的因素。若病历中有记录或因堵塞相关问题使用组织纤溶酶原激活剂时,则定义为发生堵塞。采用混合效应逻辑回归来预测堵塞情况,并对患者、医护人员、导管及医院层面的特征进行控制。
共纳入13408例患者置入的14278根PICC。其中,1684例患者的1716根PICC(12%)发生堵塞。PICC置入的最常见适应证为静脉抗生素治疗(32.7%)、静脉穿刺困难(21.5%)及中心静脉通路建立(13.7%)。与左臂置入的PICC相比,右臂置入的PICC堵塞几率降低(优势比[OR]=0.82;95%置信区间[CI]=0.72-0.94)。置管后导管尖端位置的确认与堵塞减少相关(OR=0.75;95%CI=0.61-0.92)。尽管生理盐水或肝素封管并未降低堵塞发生率,但用生理盐水封管并用肝素“锁管”的PICC堵塞可能性较小(OR=0.54;95%CI=0.33-0.88)。与单腔导管相比,双腔和三腔PICC堵塞发生率更高(双腔,OR=3.07;95%CI=2.56-3.67;三腔,OR=3.72;95%CI=2.92-4.74)。导管尖端位置不当也与堵塞相关(OR=1.46;95%CI=1.14-1.87)。
一些患者、医护人员及导管特征似乎与PICC堵塞相关。针对这些因素的干预措施可能对减少该并发症具有重要价值。